TF and cancer: In this context, and considering the various targets associated with ferroptosis, iron-chelating drugs mobilizing transferrin and ferritin iron as well as iron released during ferritinophagy could, in principle, be used as main, adjuvant or synergistic therapies for reducing or inhibiting cancer cell proliferation, metastasis and immune escape.